我公司长期供应常规性的生物试剂,耗材批发零售。秉承质量第一 信誉至上 售后完善 以客户标准为原则,为新老客户提供一个值得信任的平台。各种优势产品:life (脂质体2000,3000),Gelred(核酸染料) 。Trizol,TRIzol® LS 。罗氏潮霉素B。 二甲基亚砜(DMSO)。HyClone培养基。gibco 双抗 胰酶 B27 胎牛血清( 16000-044) 胎牛血清( 10099-141) 等。 CST ,ABcam ,santa抗体。日本同仁CCK-8试剂盒。西班牙琼脂糖。另有 sigma,amresco原装试剂大量现货。以上报价均为市场报价,仅供参考!欢迎新老客户咨询选购!18915418616
EchelonBiosciences目的在于进一步发展的脂质的细胞信号转导的关键代谢酶的科学,它提供了对癌症,心血管疾病疾病,糖尿病,炎症,感染的潜在的药物和诊断发展的新的和可行的目标。
EchelonBiosciences为生命科学社区提供的产品包括:
抗体 分析检测试剂盒
抑制剂 细胞信号产品
脂类代谢 标记物
Z-R015 Anti-huVps34(ClassIIIPI3-Kinase)AntibodyforIP
抗体 Z-R016 Anti-huVps34(ClassIIIPI3-Kinase)AntibodyforWB
K-1000 PI3-KELISAKit
试剂盒 K-1000S PI3-KELISA:PicoAssay
K-1100 PI3-KFluorescencePolarizationKit
K-1300 PI3-KAlphaScreen®
K-2700S TRueFRETPI3-KActivityAssay
K-3000 ClassIIIPI3-KELISAKit
P27-18H PI3-K(p-110alpha/p85alpha)ActiveEnzyme
酶 P28-10H PI3-K(p-110beta/p85alpha)ActiveEnzyme
B-0021 Resveratrol(ClassIAPI3-KInhibitor)
抑制剂 B-0222 Wortmannin(PI3-KinaseInhibitor)
B-0294 PI3-KinaseInhibitor(LY294002)
B-0301 PI3-KinaseGammaInhibitor1(AS605240)
B-0302 PI3-KinaseGammaInhibitor2(AS604850
B-0303 PI3-KinaseAlphaInhibitor1(PI-103)
B-0304 PI3-KinaseAlphaInhibitor2
EchelonBiosciences Incorporated(EBI)wasincorporatedunderthelawsofthestateofUtahasEchelonResearchLaboratories,Inc.onOctober3,1997.Initially, EchelonBiosciences EBIwasformedfromaprojectundertheCenterforCellSignaling,aStateofUtahCenterofExcellence,withtheaimtofurtherthescienceoflipidcellsignalingandcriticalmetabolicenzymes,whichprovidenewandviabletargetsforthedevelopmentofpotentialdrugsanddiagnosticsforcancer,diabetes,inflammation,infections,andcardiovasculardisease.
From1997through2004, EchelonBiosciences EBIprimarilyusedgovernmentgrantsandproductsalesrevenuestofunditsresearchefforts.Inearly2005,EBIwaspurchasedbyAeternaZentaris(NAS:AEZS)foritsMEPanti-infectives,PI3-Kinasesmallmoleculeprogram,catalogbusiness,andscientificexpertise.Inlate2007,FrontierScientificIncorporated(FSI)basedinLogan,UtahpurchasedEBI.Specializinginporphyrinandboronchemistry,FSIopenedthedoorsforexpandedresearch.
Since1997, EchelonBiosciences EBIhasretaineditscommitmenttodevelopingnovel*****sandreagentsforlipidresearchandbeyond.AtEBI’scoreisthedesiretoinnovate,thuspushingmedicinalresearchtonewlimits.Welookforwardtoprovidingscientistsaroundtheworldwiththetoolstheyneedtocurehumandiseasestatesforyearstocomeandwewelcomeanysuggestionsabouthowwecanbetterdoso.
